Francois Rochon
Giverny Capital
Francois Rochon SLEEP NUMBER CORP stake
total: 126
Giverny Capital SNBRQ trades
- Total transactions:
- 15
- New positions:
- 1
- Sold out:
- 1
- Added:
- 8
- Reduced:
- 5
- Held since:
- 2020 Q1
- Held for:
- 14 quarters
- Latest activity:
- 2023 Q3
According to 2026 Q2 report, Francois Rochon doesn't hold any SLEEP NUMBER CORP (SNBRQ) shares. To date, the estimated cost basis is nearly $45.51 for "buy" trades and estimated average "sell" price is $30.33. Giverny Capital first purchased SNBRQ in 2020 Q1, initially acquiring 216,108 shares. Since the initial investment in SLEEP NUMBER CORP (SNBRQ), Giverny Capital has made 14 more transactions.
When did Francois Rochon sell SLEEP NUMBER CORP (SNBRQ)?
Francois Rochon sold off the entire SLEEP NUMBER CORP (SNBRQ) position in 2023 Q3.
When did Francois Rochon buy SLEEP NUMBER CORP (SNBRQ)?
Francois Rochon first invested in SLEEP NUMBER CORP (SNBRQ) in 2020 Q1 at the reported quarter-end price of $19.16 per share.
What's the cost basis of Giverny Capital's SNBRQ stake?
The estimated cost basis for SLEEP NUMBER CORP (SNBRQ) stake is around $45.51 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $45.50
- Weighted AVG sell price:
- $30.33
Francois Rochon's historical trades in SLEEP NUMBER CORP
15 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2023 Q3
|
0.00%
|
0
|
$27.28
|
|
-100% (-21,057)
|
-0.03%
|
|
2023 Q2
|
0.03%
|
21,057
|
$27.28
|
$574,435
|
-0.10% (-22)
|
-0%
|
|
2023 Q1
|
0.04%
|
21,079
|
$30.41
|
$641,012
|
-94.46% (-359,184)
|
-0.68%
|
|
2022 Q4
|
0.61%
|
380,263
|
$25.98
|
$9,879,233
|
-1.55% (-5,999)
|
-0.01%
|
|
2022 Q3
|
0.88%
|
386,262
|
$33.81
|
$13,060,000
|
+1.01% (+3,859)
|
+0.01%
|
|
2022 Q2
|
0.78%
|
382,403
|
$30.95
|
$11,835,000
|
+6.03% (+21,763)
|
+0.04%
|
|
2022 Q1
|
1.03%
|
360,640
|
$50.71
|
$18,288,000
|
+0.57% (+2,050)
|
+0.01%
|
|
2021 Q4
|
1.47%
|
358,590
|
$76.60
|
$27,468,000
|
+3.31% (+11,499)
|
+0.05%
|
|
2021 Q3
|
1.93%
|
347,091
|
$93.48
|
$32,446,000
|
-0.01% (-49)
|
-0%
|
|
2021 Q2
|
2.32%
|
347,140
|
$109.95
|
$38,168,000
|
+2.15% (+7,294)
|
+0.05%
|
|
2021 Q1
|
3.26%
|
$143.49
|
+3.06% (+10,088)
|
|||
|
2020 Q4
|
2.07%
|
$81.86
|
+54.52% (+116,348)
|
|||
|
2020 Q3
|
0.96%
|
$48.91
|
-1.46% (-3,159)
|
|||
|
2020 Q2
|
0.90%
|
$41.64
|
+0.21% (+461)
|
|||
|
2020 Q1
|
0.53%
|
$19.16
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.